Overexpression of ERβ is sufficient to inhibit hypoxia-inducible factor-1 transactivation

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 261-266

  Park, Choa ^a   Lee, Youngjoo ^a  

^a Sejong University   (South Korea)

Author keywords

Estrogen receptor beta; Hypoxia; Hypoxia inducible factor 1

Indexed keywords

DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1BETA; LUCIFERASE; VASCULOTROPIN;

ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; HYPOXIA; MCF 7 CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REPORTER GENE; TRANSACTIVATION; UBIQUITINATION;

ESTROGEN RECEPTOR BETA; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR-1;

CELL HYPOXIA; CELL LINE, TUMOR; ESTROGEN RECEPTOR BETA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; OXYGEN; UP-REGULATION;

EID: 84904721912     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.107     Document Type: Article

References (30)

1. Y.F. Hou, S.T. Yuan, H.C. Li, J. Wu, J.S. Lu, G. Liu, L.J. Lu, Z.Z. Shen, J. Ding, and Z.M. Shao ERbeta exerts multiple stimulative effects on human breast carcinoma cells Oncogene 23 2004 5799 5806
2. J. Rüegg, E. Swedenborg, D. Wahlström, A. Escande, P. Balaguer, K. Pettersson, and I. Pongratz The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin Mol. Endocrinol. 22 2008 304 316
3. A. Ström, J. Hartman, J.S. Foster, S. Kietz, J. Wimalasena, and J.A. Gustafsson Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D Proc. Natl. Acad. Sci. U.S.A. 101 2006 1566 1571
4. S. Paruthiyil, H. Parmar, V. Kerekatte, G.R. Cunha, G.L. Firestone, and D.C. Leitman Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest Cancer Res. 64 2004 423 428
5. A.M. Sotoca, H. van den Berg, J. Vervoort, P. van der Saag, A. Ström, J.A. Gustafsson, I. Rietjens, and A.J. Murk Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells Toxicol. Sci. 105 2008 303 311
6. J. Hartman, K. Lindberg, A. Morani, J. Inzunza, A. Ström, and J.A. Gustafsson Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts Cancer Res. 66 2006 11207 11213
7. J. Hartman, K. Edvardsson, K. Lindberg, C. Zhao, C. Williams, A. Ström, and J.A. Gustafsson Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells Cancer Res. 69 2009 6100 6106
8. P. Mak, C. Chang, B. Pursell, and A.M. Mercurio Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription Proc. Natl. Acad. Sci. U.S.A. 110 2013 4708 4713
9. C. Thomas, G. Rajapaksa, F. Nikolos, R. Hao, A. Katchy, C.W. McCollum, M. Bondesson, P. Quinlan, A. Thompson, S. Krishnamurthy, F.J. Esteva, and J.A. Gustafsson ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR Breast Cancer Res. 14 2012 R148
10. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
11. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat. Rev. Cancer 2 2002 38 47
12. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732
13. J.D. Gordan, and M.C. Simon Hypoxia-inducible factors: central regulators of the tumor phenotype Curr. Opin. Genet. Dev. 17 2007 71 77
14. P.J. Kallio, K. Okamoto, S. O'Brien, P. Carrero, Y. Makino, H. Tanaka, and L. Poellinger Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha EMBO J. 17 1998 6573 6586
15. P.J. Kallio, I. Pongratz, K. Gradin, J. McGuire, and L. Poellinger Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor Proc. Natl. Acad. Sci. U.S.A. 94 1997 5667 5672
16. S. Brunnberg, K. Pettersson, E. Rydin, J. Matthews, A. Hanberg, and I. Pongratz The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription Proc. Natl. Acad. Sci. U.S.A. 100 2003 6517 6522
17. D. Arsenault, K. Brochu-Gaudreau, M. Charbonneau, and C.M. Dubois HDAC6 deacetylase activity is required for hypoxia-induced invadopodia formation and cell invasion PLoS ONE 8 2013 e55529
18. B. Krishnamachary, S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, and G.L. Semenza Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1 Cancer Res. 63 2003 1138 1143
19. S. McMahon, F. Grondin, P.P. McDonald, D.E. Richard, and C.M. Dubois Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins J. Biol. Chem. 280 2005 6561 6569
20. W. Lim, Y. Park, J. Cho, C. Park, J. Park, Y.K. Park, H. Park, and Y. Lee Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator Breast Cancer Res. 13 2011 R32
21. P. Mak, I. Leav, B. Pursell, D. Bae, X. Yang, C.A. Taglienti, L.M. Gouvin, V.M. Sharma, and A.M. Mercurio ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading Cancer Cell 17 2010 319 332
22. W. Lim, C. Park, M.K. Shim, Y.H. Lee, Y.M. Lee, and Y. Lee Glucocorticoid represses hypoxia-induced cyclooxygenase-2 and hypoxia inducible factor-1α expression through induction of the glucocorticoid-induced leucine zipper Br. J. Pharmacol. 171 2014 735 745
23. D.P. Xirodimas, M.K. Saville, J.C. Bourdon, R.T. Hay, and D.P. Lane Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity Cell 118 2004 83 97
24. D. Chen, M. Li, J. Luo, and W. Gu Direct interactions between HIF-1α and Mdm2 modulate p53 function J. Biol. Chem. 278 2003 13595 13598
25. L.O. Hansson, A. Friedler, S. Freund, S. Rudiger, and A.R. Fersht Two sequence motifs from HIF-1α bind to the DNA binding site of p53 Proc. Natl. Acad. Sci. U.S.A. 99 2002 10305 10309
26. S. Saji, N. Okumura, H. Eguchi, S. Nakashima, A. Suzuki, M. Toi, Y. Nozawa, S. Saji, and S. Hayashi MDM2 enhances the function of estrogen receptor α in human breast cancer cells Biochem. Biophys. Res. Commun. 281 2001 259 265
27. H.J. Lee, and K.W. Kim Suppression of HIF-1α by valproic acid sustains self-renewal of mouse embryonic stem cells under hypoxia in vitro Biomol. Ther. (Seoul) 20 2012 280 285
28. A. Hu, C. Shang, Q. Li, N. Sun, L. Wu, Y. Ma, X. Jiao, J. Min, G. Zeng, and X. He Epithelial-mesenchymal transition delayed by E-cad to promote tissue formation in hepatic differentiation of mouse embryonic stem cells in vitro Stem Cells Dev. 24 2013 10.1089
29. I. Stasinopoulos, T. Shah, M.F. Penet, B. Krishnamachary, and Z.M. Bhujwalla COX-2 in cancer: Gordian knot or Achilles heel? Front. Pharmacol. 4 2013 34
30. M. Tsujii, S. Kawano, and R.N. DuBois Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc. Natl. Acad. Sci. U.S.A. 94 1997 3336 3340